|
Delayed
Australian S.E.
00:10:11 2026-11-04 EST
|
5-day change | 1st Jan Change | ||
| 0.5400 AUD | -5.26% |
|
+0.93% | -50.23% |
Company Valuation: Orthocell Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 79.84 | 285.9 | 197.4 | 147.1 | - | - |
| Change | - | - | -30.97% | -25.48% | - | - |
| Enterprise Value (EV) 1 | 79.84 | 285.9 | 153.4 | 118.8 | 123.3 | 117.3 |
| Change | - | - | -46.34% | -22.54% | 3.74% | -4.83% |
| P/E | -8.62x | -30.9x | -13.7x | -10.8x | -27x | 27x |
| PBR | - | - | 5.55x | 6x | 4.5x | 2.7x |
| PEG | - | - | -0.3x | 1.91x | 0.5x | -0x |
| Capitalization / Revenue | - | - | 17.3x | 9.22x | 4.8x | 2.84x |
| EV / Revenue | - | - | 13.5x | 7.45x | 4.02x | 2.27x |
| EV / EBITDA | - | - | -10.3x | -9.18x | -21.3x | 35.6x |
| EV / EBIT | - | - | -9.75x | -8.37x | -16.5x | 73.3x |
| EV / FCF | - | - | -11.1x | -6.83x | -10.4x | -23.5x |
| FCF Yield | - | - | -9.02% | -14.6% | -9.65% | -4.26% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.047 | -0.038 | -0.053 | -0.05 | -0.02 | 0.02 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | - | 11.41 | 15.95 | 30.65 | 51.75 |
| EBITDA 1 | - | - | -14.87 | -12.95 | -5.8 | 3.3 |
| EBIT 1 | - | - | -15.73 | -14.2 | -7.45 | 1.6 |
| Net income 1 | -9.107 | -8.567 | -13.91 | -14.4 | -7.75 | 1.3 |
| Net Debt 1 | - | - | -43.95 | -28.25 | -23.8 | -29.75 |
| Reference price 2 | 0.4050 | 1.1750 | 0.7250 | 0.5400 | 0.5400 | 0.5400 |
| Nbr of stocks (in thousands) | 197,128 | 243,344 | 272,254 | 272,394 | - | - |
| Announcement Date | 8/30/22 | 8/29/25 | 8/31/26 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -11.4x | 7.96x | -9.81x | - | 108M | |
| 36.19x | 4.26x | 16x | 2.37% | 189B | |
| 21.41x | 3.65x | 13.06x | 2.87% | 121B | |
| 26.65x | 4.77x | 16.3x | 1.17% | 118B | |
| 32.33x | 3.11x | 12.55x | 2.2% | 94.78B | |
| 18.06x | 0.21x | 13.47x | 0.7% | 64.98B | |
| 40.39x | 3.62x | 12.33x | 2.11% | 53.98B | |
| 45.22x | 11.15x | 31.32x | -.--% | 52.94B | |
| 29.79x | 7.43x | 18.98x | 1.36% | 52.3B | |
| 43.21x | 3.42x | 12.7x | 0.51% | 35.25B | |
| Average | 28.19x | 4.96x | 13.69x | 1.48% | 78.29B | |
| Weighted average by Cap. | 31.28x | 4.36x | 15.79x | 1.78% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- OCC Stock
- Valuation Orthocell Limited
Select your edition
All financial news and data tailored to specific country editions
